2020
DOI: 10.1016/j.ejmech.2020.112309
|View full text |Cite
|
Sign up to set email alerts
|

Design, synthesis and biological activity of novel 2,3,4,5-tetra-substituted thiophene derivatives as PI3Kα inhibitors with potent antitumor activity

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 8 publications
(2 citation statements)
references
References 25 publications
0
2
0
Order By: Relevance
“…The IC 50 values for these compounds 16a 16 The structure of curcumin-resveratrol-Nacylhydrazones 16a-c CCNB1, PLK1, AURKA, and AURKB enzymes, while simultaneously increasing CDKN1A (p21). [73] Liao et al [74] developed a variety of new 2,3,4,5-tetrasubstituted thiophene derivatives with an N-acylarylhydrazone scaffold using a rational design technique for the isoform-selective inhibition of phosphatidylinositol 3-kinase (PI3Kα). The most effective molecule, 17 (Figure 17) had been refined to a level equivalent to PF-4989216 and displayed an IC 50 of 6.5 nM against PI3Kα.…”
Section: N-acylhydrazones As Tyrosine Kinase Inhibitorsmentioning
confidence: 99%
“…The IC 50 values for these compounds 16a 16 The structure of curcumin-resveratrol-Nacylhydrazones 16a-c CCNB1, PLK1, AURKA, and AURKB enzymes, while simultaneously increasing CDKN1A (p21). [73] Liao et al [74] developed a variety of new 2,3,4,5-tetrasubstituted thiophene derivatives with an N-acylarylhydrazone scaffold using a rational design technique for the isoform-selective inhibition of phosphatidylinositol 3-kinase (PI3Kα). The most effective molecule, 17 (Figure 17) had been refined to a level equivalent to PF-4989216 and displayed an IC 50 of 6.5 nM against PI3Kα.…”
Section: N-acylhydrazones As Tyrosine Kinase Inhibitorsmentioning
confidence: 99%
“…Among the various isoforms of PI3K, PI3Kα over expression leads to the occurrence of various types of cancer like colon, brain, breast, endometrial tumors and non-small cell lung cancer (NSCLC). [52] Among different possible molecular targets, targeting PI3Kα will effectively inhibit NSCLC.…”
Section: Molecular Docking Studiesmentioning
confidence: 99%